JPRN-UMIN000020440已完成1 期
A combination immunotherapy for the patients with advanced or metastatic solid cancer - A combination immunotherapy for the patients with advanced or metastatic solid cancer
Yamaguchi university Graduate School of Medicine0 个研究点目标入组 17 人开始时间: 2016年2月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Uncontroled general complication. etc
研究者
相似试验
进行中（未招募）
1 期
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)Immune thrombocytopeniaMedDRA version: 23.0Level: PTClassification code: 10083842Term: Immune thrombocytopenia Class: 100000004851CTIS2023-505788-35-00Fakultni Nemocnice Hradec Kralove73
招募中
2 期
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase IIAsthmaBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesEnvironmental IllnessRPCEC00000240ational Center of Bioproducts (BIOCEN)120
已完成
1 期
A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancercolorectal cancerJPRN-UMIN000022082Yamaguchi University12
招募中
不适用
Safety and efficacy of combination immunotherapy with nivolumab and ipilimumab for elderly lung cancer patients: a cohort studynon-small cell lung cancerJPRN-UMIN000046353ational Hospital Organization Kyoto Medical Center60
已完成
不适用
Combined therapy with immune-suppressive drug in children with immunoglobulin resistant Kawasaki diseaseKawasaki diseaseJPRN-UMIN000032096Dokkyo medical university52